why choose us

First received: March 08, 2023

Clinical Trial: A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

Study Status: Completed

Recruit Status: RECRUITING

Condition: Growth Hormone Deficiency

Study Type: OBSERVATIONAL


Official Title: A Prospective, Non-interventional (NIS), Long-term, Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

Brief Summary: The goal of this study is to further characterise the potential long-term safety risks of lonapegsomatropin in patients treated with lonapegsomatropin under real-world conditions in the post-marketing setting.

Read more